Literature DB >> 26854278

Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China.

Lijun Tang1, Jing Yao2, Xianglei Kong1, Qing Sun3, Zunsong Wang1, Ying Zhang1, Ping Wang1, Yipeng Liu1, Wenbin Li1, Meiyu Cui1, Junhui Zhen4, Dongmei Xu1.   

Abstract

AIM: Primary glomerular disease (PGD) remains the most common renal disease in China. A limited number of single centre studies show that the frequency of membranous nephropathy (MN) has increased; however, IgA nephropathy (IgAN) is still the most common PGD. To the best of our knowledge, there has been no multi-centre study in China that has explored the changes in PGD spectrum. To further investigate the changes in renal histopathological spectrum, we performed the cross-sectional study.
METHOD: From June 2010 to May 2015, 5935 patients from 37 hospitals in Shandong Province were involved in this retrospective study. The study was divided into five periods according to 1-year intervals. The patients were divided into four age groups (≤18 years, 19-44 years, 45-59 years and ≥60 years). RESULT: Among the 5935 qualified specimens, 4855 (81.8%) were diagnosed with PGD. MN (43.3%) became the most common PGD instead of IgA (34.1%) (P < 0.001). The frequency of MN was increased from 30.7% in period 1 to 53.5% in period 5 (P < 0.001). The prevalence of MN tended to increase in every age section. IgA was the main cause of PGD in periods 1 and 2; however, its proportion decreased significantly from 41.8% in period 2 to 25.2% in period 5 (P < 0.001).
CONCLUSION: Primary glomerular disease remains the most common renal disease in our study. For the first time, this cross-sectional study suggests that MN, in place of IgAN, has grown to be the first leading pathological type of PGD.
© 2016 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  IgA nephropathy; histopathology; membranous nephropathy; primary glomerular diseases

Mesh:

Year:  2017        PMID: 26854278     DOI: 10.1111/nep.12739

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  11 in total

1.  How many podocyte autophagosomes are there in immunoglobulin A nephropathy and idiopathic membranous nephropathy?

Authors:  Shikai Liang; Juan Jin; Jianguang Gong; Bo Lin; Yiwen Li; Qiang He
Journal:  Int Urol Nephrol       Date:  2016-08-31       Impact factor: 2.370

2.  Association of podocyte autophagosome numbers with idiopathic membranous nephropathy and secondary membranous nephropathy.

Authors:  Juan Jin; Huifang Zhan; Bo Lin; Yiwen Li; Wei Zhang; Qiang He
Journal:  Int Urol Nephrol       Date:  2017-03-11       Impact factor: 2.370

3.  Clinicopathological features of atypical membranous nephropathy with unknown etiology in adult Chinese patients.

Authors:  Zhenbin Jiang; Meishun Cai; Bao Dong; Yu Yan; Bing Yang; Mi Wang; Yan Wang; Xin Li; Lichao Lian; Song Li; Li Zuo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

4.  Identification of a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for chronic kidney disease using next-generation sequencing.

Authors:  Xinying Liu; Weijie Wang; Yaling Bai; Huiran Zhang; Shenglei Zhang; Lei He; Wei Zhou; Dongxue Zhang; Jinsheng Xu
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

5.  Salivary microbiota analysis of patients with membranous nephropathy.

Authors:  Shaodong Luan; Shuyuan Zhang; Litao Pan; Wenjun Hu; Haihong Cui; Xing Wei; Renyong Lin; Chundi Li; Ping Zeng; Xi Wang; Weilong Li; Zigan Xu; Yingwei Zhang; Bo Hu; Hanchao Gao
Journal:  Mol Med Rep       Date:  2022-04-01       Impact factor: 2.952

Review 6.  The Genetic and Environmental Factors of Primary Membranous Nephropathy: An Overview from China.

Authors:  Xiao-Dan Zhang; Zhao Cui; Ming-Hui Zhao
Journal:  Kidney Dis (Basel)       Date:  2018-04-04

7.  Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery.

Authors:  Tianqi Tu; Xueling Wei; Yue Yang; Nianrong Zhang; Wei Li; Xiaowen Tu; Wenge Li
Journal:  BMC Nephrol       Date:  2021-06-19       Impact factor: 2.388

8.  Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.

Authors:  Peihong Yin; Junxian Wang; Wenyi Liang; Linda Zhan; Yuanhao Liu; Jian Lin; Xiaohong Chen; Yingqin He; Hongyun Jian; Zhibin Xie; Xiaofan Tan; Qing Ye; Fengxian Huang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

9.  Changes in the diagnosis of glomerular diseases in east China: a 15-year renal biopsy study.

Authors:  Qin Zhou; Xin Yang; Meifang Wang; Huiping Wang; Jie Zhao; Yan Bi; Xiayue Wang; Jihong Yao; Ying Chen; Chuan Lin; Xishao Xie; Hong Jiang; Jianghua Chen
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

Review 10.  B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management.

Authors:  Benjamin Y F So; Desmond Y H Yap; Tak Mao Chan
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.